StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday. A number of other analysts have also recently issued reports on ABEO. HC Wainwright reissued a “buy” rating and issued a $15.00 price objective on […]
Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday. A number of other analysts have also recently issued reports on ABEO. HC Wainwright reissued a “buy” rating and issued a $15.00 price objective on […]
